BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng X, Xu C, Cheng J, Sun C, Wang Z, Gong Z, Long H, Zhu B. Poor glycemic control might compromise the efficacy of chemotherapy in non-small cell lung cancer patients with diabetes mellitus. Cancer Med 2020;9:902-11. [PMID: 31830375 DOI: 10.1002/cam4.2750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Zeng X, Xu C, Cheng J, Sun C, Wang Z, Gong Z, Long H, Zhu B. Poor glycemic control might compromise the efficacy of chemotherapy in non-small cell lung cancer patients with diabetes mellitus. Cancer Med 2020;9:902-11. [PMID: 31830375 DOI: 10.1002/cam4.2750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Ji Y, Zhang G, Zhang X. Identification of LncRNA CARD8-AS1 as a Potential Prognostic Biomarker Associated With Progression of Lung Adenocarcinoma. Br J Biomed Sci 2022;79:10498. [DOI: 10.3389/bjbs.2022.10498] [Reference Citation Analysis]
3 Ashley L, Kassim S, Kellar I, Kidd L, Mair F, Matthews M, Price M, Swinson D, Taylor J, Velikova G, Wadsley J. Identifying ways to improve diabetes management during cancer treatments (INDICATE): protocol for a qualitative interview study with patients and clinicians. BMJ Open 2022;12:e060402. [PMID: 35193924 DOI: 10.1136/bmjopen-2021-060402] [Reference Citation Analysis]